Canakinumab (Anti-IL-1b)

Selleck Chemicals

Canakinumab (Anti-IL-1b)

9

Research Use Only

...

Canakinumab (Anti-IL-1b) is a recombinant human anti-IL-1beta monoclonal antibody targeting IL-1beta and neutralizing IL-1beta signaling. It can be used in treatment of disorders of autoimmune origin like familial mediterranean fever, mevalonate kinase deficiency, tumor necrosis factor receptor-associated periodic syndrome (TRAPS). MW :145.5 KD.

-20°C

12352203